These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9888762)

  • 1. Cardiac pacemakers and implantable cardioverter defibrillators are unaffected by operation of an extremity MR imaging system.
    Shellock FG; O'Neil M; Ivans V; Kelly D; O'Connor M; Toay L; Crues JV
    AJR Am J Roentgenol; 1999 Jan; 172(1):165-70. PubMed ID: 9888762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac pacemakers and implantable cardioverter defibrillators: in vitro magnetic resonance imaging evaluation at 1.5-tesla.
    Shellock FG; Fischer L; Fieno DS
    J Cardiovasc Magn Reson; 2007; 9(1):21-31. PubMed ID: 17178677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices.
    Roguin A; Schwitter J; Vahlhaus C; Lombardi M; Brugada J; Vardas P; Auricchio A; Priori S; Sommer T
    Europace; 2008 Mar; 10(3):336-46. PubMed ID: 18308754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T.
    Naehle CP; Kreuz J; Strach K; Schwab JO; Pingel S; Luechinger R; Fimmers R; Schild H; Thomas D
    Am Heart J; 2011 Jun; 161(6):1096-105. PubMed ID: 21641356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of electromagnetic articulography in patients with pacemakers and implantable cardioverter-defibrillators.
    Joglar JA; Nguyen C; Garst DM; Katz WF
    J Speech Lang Hear Res; 2009 Aug; 52(4):1082-7. PubMed ID: 19641084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR in patients with pacemakers and ICDs: Defining the issues.
    Shinbane JS; Colletti PM; Shellock FG
    J Cardiovasc Magn Reson; 2007; 9(1):5-13. PubMed ID: 17178675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions.
    Mollerus M; Albin G; Lipinski M; Lucca J
    Europace; 2010 Jul; 12(7):947-51. PubMed ID: 20353963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of neodymium magnets with cardiac pacemakers and implantable cardioverter-defibrillators: an in vitro study.
    Ryf S; Wolber T; Duru F; Luechinger R
    Technol Health Care; 2008; 16(1):13-8. PubMed ID: 18334784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan.
    Mollerus M; Albin G; Lipinski M; Lucca J
    Pacing Clin Electrophysiol; 2008 Oct; 31(10):1241-5. PubMed ID: 18811802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator.
    Roguin A; Donahue JK; Bomma CS; Bluemke DA; Halperin HR
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):336-8. PubMed ID: 15826272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan.
    Mollerus M; Albin G; Lipinski M; Lucca J
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):772-8. PubMed ID: 19545340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsule endoscopy in patients with cardiac pacemakers and implantable cardioverter-defibrillators - a retrospective multicenter investigation.
    Bandorski D; Lotterer E; Hartmann D; Jakobs R; Brück M; Hoeltgen R; Wieczorek M; Brock A; de Rossi T; Keuchel M
    J Gastrointestin Liver Dis; 2011 Mar; 20(1):33-7. PubMed ID: 21451795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of implantable pacemakers and cardioverter defibrillators in the magnetic field of a novel remote magnetic navigation system.
    Jilek C; Tzeis S; Reents T; Estner HL; Fichtner S; Ammar S; Wu J; Hessling G; Deisenhofer I; Kolb C
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1136-41. PubMed ID: 20522155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T.
    Roguin A; Zviman MM; Meininger GR; Rodrigues ER; Dickfeld TM; Bluemke DA; Lardo A; Berger RD; Calkins H; Halperin HR
    Circulation; 2004 Aug; 110(5):475-82. PubMed ID: 15277324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro tests reveal sample radiofrequency identification readers inducing clinically significant electromagnetic interference to implantable pacemakers and implantable cardioverter-defibrillators.
    Seidman SJ; Brockman R; Lewis BM; Guag J; Shein MJ; Clement WJ; Kippola J; Digby D; Barber C; Huntwork D
    Heart Rhythm; 2010 Jan; 7(1):99-107. PubMed ID: 20129290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac magnetic resonance imaging at 1.5 T in patients with cardiac rhythm devices.
    Buendía F; Cano Ó; Sánchez-Gómez JM; Igual B; Osca J; Sancho-Tello MJ; Olagüe J; Salvador A
    Europace; 2011 Apr; 13(4):533-8. PubMed ID: 21227955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety of cardiac pacemakers and implantable cardioverter-defibrillators in magnetic resonance imaging. Assessment of the aggregate function at 1.5 tesla].
    Nordbeck P; Bauer WR
    Dtsch Med Wochenschr; 2008 Mar; 133(13):624-8. PubMed ID: 18351504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac pacemakers, ICDs, and loop recorder: evaluation of translational attraction using conventional ("long-bore") and "short-bore" 1.5- and 3.0-Tesla MR systems.
    Shellock FG; Tkach JA; Ruggieri PM; Masaryk TJ
    J Cardiovasc Magn Reson; 2003; 5(2):387-97. PubMed ID: 12765117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac pacemaker: in vitro assessment at 1.5 T.
    Shellock FG; Fieno DS; Thomson LJ; Talavage TM; Berman DS
    Am Heart J; 2006 Feb; 151(2):436-43. PubMed ID: 16442911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.